Overview Evaluating the Pharmacokinetic Interaction Between AD-2101 and AD-2102 Status: Completed Trial end date: 2021-04-30 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the Pharmacokinetic Interaction Between AD-2101 and AD-2102 in healthy male subjects. Phase: Phase 1 Details Lead Sponsor: Addpharma Inc.